Indication
Treatment of adult patients with paroxysmal nocturnal haemoglobinuria (PNH) who are anaemic after treatment with a C5 inhibitor for at least 3 months.
Medicine details
- Medicine name:
- pegcetacoplan (Aspaveli)
- SMC ID:
- SMC2451
- Pharmaceutical company
- Swedish Orphan Biovitrum
- BNF chapter
- Nutrition and blood
- Submission type
- Full
- Publication due date:
- TBC
- SMC meeting date:
- TBC
- Patient group submission deadline:
- 02 May 2022